CymitQuimica logo

NCL 00017509

CAS:

Ref. 3D-HKC36700

5mg
Discontinued
10mg
Discontinued
25mg
Discontinued
50mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

NCL 00017509
Biosynth

    Product Information

    Name:NCL 00017509
    Brand:Biosynth
    Description:NCL 00017509 is a small molecule drug that is being developed as an anticancer agent. The compound has shown growth-inhibitory activity in tumour cell lines and has been shown to bind to specific DNA sequences. This drug also synergizes with other cancer drugs, such as cisplatin, to produce more effective treatments. NCL 00017509 has been shown to inhibit the proliferation of various types of human cancer cells, including colon cancer cells and prostate cancer cells. It prevents the expression of proteins that cause uncontrolled cell division by binding irreversibly to dna at specific sites. NCL 00017509 is currently being investigated for its ability to suppress the growth of non-small cell lung cancers and some types of breast cancers.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:292.3 g/mol
    Formula:C15H12N6O
    Purity:Min. 95%

    Inquiry about discontinued product: NCL 00017509

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.